Skip to main content
. 2024 May 17;12(5):549. doi: 10.3390/vaccines12050549

Table 1.

Adherence to nirsevimab prophylaxis in those born in Valle d’Aosta, Italy from 1 May 2023 to 15 February 2024.

Period Total Births Candidates for
Palivizumab
Non- Residents Candidates for Nirsevimab Treated with Nirsevimab No Prophylaxis Coverage
01/05/2023 18/12/2023 461 13 0 448 292 156 65%
19/12/2023 15/02/2024 95 3 3 89 77 12 86%
Total 556 16 3 537 369 168 69%